- Home
- GNTA vs SRBK Comparison
GNTA vs SRBK Comparison
Compare GNTA & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTA
- SRBK
- Stock Information
- Founded
- GNTA 2014
- SRBK 1887
- Country
- GNTA Italy
- SRBK United States
- Employees
- GNTA N/A
- SRBK N/A
- Industry
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- SRBK
- Sector
- GNTA Health Care
- SRBK
- Exchange
- GNTA Nasdaq
- SRBK Nasdaq
- Market Cap
- GNTA 59.7M
- SRBK 117.4M
- IPO Year
- GNTA 2021
- SRBK N/A
- Fundamental
- Price
- GNTA $2.56
- SRBK $14.76
- Analyst Decision
- GNTA
- SRBK
- Analyst Count
- GNTA 0
- SRBK 0
- Target Price
- GNTA N/A
- SRBK N/A
- AVG Volume (30 Days)
- GNTA 1.9M
- SRBK 25.1K
- Earning Date
- GNTA 01-01-0001
- SRBK 10-30-2025
- Dividend Yield
- GNTA N/A
- SRBK 1.36%
- EPS Growth
- GNTA N/A
- SRBK 374.69
- EPS
- GNTA N/A
- SRBK 0.54
- Revenue
- GNTA N/A
- SRBK $31,130,000.00
- Revenue This Year
- GNTA N/A
- SRBK N/A
- Revenue Next Year
- GNTA N/A
- SRBK N/A
- P/E Ratio
- GNTA N/A
- SRBK $27.17
- Revenue Growth
- GNTA N/A
- SRBK 0.85
- 52 Week Low
- GNTA $2.33
- SRBK $10.75
- 52 Week High
- GNTA $10.00
- SRBK $15.46
- Technical
- Relative Strength Index (RSI)
- GNTA 44.53
- SRBK 50.28
- Support Level
- GNTA $2.54
- SRBK $14.60
- Resistance Level
- GNTA $10.00
- SRBK $14.94
- Average True Range (ATR)
- GNTA 0.62
- SRBK 0.22
- MACD
- GNTA -0.11
- SRBK 0.01
- Stochastic Oscillator
- GNTA 3.00
- SRBK 64.12
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About SRBK SR Bancorp Inc. Common stock
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.